Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Agribusiness (N Y N Y) ; 37(1): 122-141, 2021.
Artículo en Inglés | MEDLINE | ID: mdl-33362337

RESUMEN

The novel coronavirus SARS-CoV2 (COVID-19) severely disrupted the U.S. food supply chain. In its initial aftermath, and as we contemplate a potential reignition, the food supply chain industries, researchers, and policy makers search for evidence, causes, and consequences. This article uses publicly available data on the pork and egg industries and a survey of the turkey industry as a first step to document the impact of COVID-19. Researchers can learn from the experiences in industries where disruptions evolve differently in the face of simultaneous supply- and demand-side shocks and that stem from differences in structures of the supply chains. This early evidence is used to motivate future research needs and highlight opportunities for industry investments in resiliency strategies.

2.
Am J Physiol Lung Cell Mol Physiol ; 285(1): L258-67, 2003 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12626332

RESUMEN

In vitro and in vivo evidence indicates that circulating platelets affect both vascular integrity and hemostasis. How platelets enhance the permeability barrier of the vascular endothelium is not well understood. We measured the effect of isolated human platelets on human pulmonary artery endothelial cell (EC) barrier integrity by monitoring transmonolayer electrical resistance. EC barrier function was significantly increased by the addition of platelets ( approximately 40% maximum, 2.5 x 106 platelets/ml). Platelet supernatants, derived from 2.5 x 106 platelets/ml, reproduced the barrier enhancement and reversed the barrier dysfunction produced by the edemagenic agonist thrombin, which implicates a soluble barrier-promoting factor. The barrier-enhancing effect of platelet supernatants was heat stable but was attenuated by either charcoal delipidation (suggesting a vasoactive lipid mediator) or pertussis toxin, implying involvement of a Gialpha-coupled receptor signal transduction pathway. Sphingosine-1-phosphate (S1P), a sphingolipid that is released from activated platelets, is known to ligate G protein-coupled EC differentiation gene (EDG) receptors, increase EC electrical resistance, and reorganize the actin cytoskeleton (Garcia JG, Liu F, Verin AD, Birukova A, Dechert MA, Gerthoffer WT, Bamberg JR, and English D. J Clin Invest 108: 689-701, 2001). Infection of EC with an adenoviral vector expressing an antisense oligonucleotide directed against EDG-1 but not infection with control vector attenuated the barrier-enhancing effect of both platelet supernatants and S1P. These results indicate that a major physiologically relevant vascular barrier-protective mediator produced by human platelets is S1P.


Asunto(s)
Plaquetas/metabolismo , Endotelio Vascular/metabolismo , Lisofosfolípidos , Receptores Acoplados a Proteínas G , Mucosa Respiratoria/metabolismo , Esfingosina/análogos & derivados , Esfingosina/metabolismo , Citoesqueleto de Actina/metabolismo , Permeabilidad de la Membrana Celular/efectos de los fármacos , Permeabilidad de la Membrana Celular/fisiología , Células Cultivadas , Impedancia Eléctrica , Endotelio Vascular/citología , Subunidades alfa de la Proteína de Unión al GTP Gi-Go/metabolismo , Uniones Comunicantes/efectos de los fármacos , Uniones Comunicantes/fisiología , Sustancias de Crecimiento/metabolismo , Hemostáticos/farmacología , Humanos , Proteínas Inmediatas-Precoces/antagonistas & inhibidores , Proteínas Inmediatas-Precoces/metabolismo , Enfermedades Pulmonares/metabolismo , Toxina del Pertussis/farmacología , Receptores de Superficie Celular/antagonistas & inhibidores , Receptores de Superficie Celular/metabolismo , Receptores Lisofosfolípidos , Mucosa Respiratoria/citología , Transducción de Señal/efectos de los fármacos , Transducción de Señal/fisiología , Esfingosina/farmacología , Trombina/farmacología
3.
FASEB J ; 16(9): 950-62, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12087056

RESUMEN

The stabilization of endothelial cell (EC) barrier function within newly formed capillaries is a critical feature of angiogenesis. We examined human lung EC barrier regulation elicited by hepatocyte growth factor (HGF), a recognized angiogenic factor and EC chemoattractant. HGF rapidly and dose-dependently elevated transendothelial electrical resistance (TER) of EC monolayers (>50% increase at 100 ng/ml), with immunofluorescence microscopic evidence of both cytoplasmic actin stress fiber dissolution and strong augmentation of the cortical actin ring. HGF rapidly stimulated phosphatidylinositol 3'-kinase, ERK, p38 mitogen-activated protein kinase, and protein kinase C activities. Pharmacological inhibitor studies demonstrated each pathway to be intimately involved in HGF-induced increases in TER, cortical actin thickening, and phosphorylation of the Ser/Thr glycogen synthase kinase-3beta (GSK-3beta), a potential target for the HGF barrier-promoting response. GSK-3beta phosphorylation was strongly correlated with reductions in both HGF-induced TER and enhanced beta-catenin immunoreactivity observed at cell-cell junctions. Our data suggest a model in which HGF-mediated EC cytoskeletal rearrangement and barrier enhancement depend critically on the activation of a complex kinase cascade that converges at GSK-3beta to increase the availability of beta-catenin, thereby enhancing endothelial junctional integrity and vascular barrier function.


Asunto(s)
Citoesqueleto de Actina/ultraestructura , Proteínas Quinasas Dependientes de Calcio-Calmodulina/fisiología , Endotelio Vascular/fisiología , Endotelio Vascular/ultraestructura , Factor de Crecimiento de Hepatocito/farmacología , Arteria Pulmonar/citología , Transactivadores , Citoesqueleto de Actina/química , Citoesqueleto de Actina/enzimología , Animales , Bovinos , Línea Celular , Permeabilidad de la Membrana Celular , Células Cultivadas , Proteínas del Citoesqueleto/análisis , Relación Dosis-Respuesta a Droga , Impedancia Eléctrica , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/enzimología , Glucógeno Sintasa Quinasa 3 , Glucógeno Sintasa Quinasas , Humanos , Cinética , Proteínas Quinasas Activadas por Mitógenos/fisiología , Fosfatidilinositol 3-Quinasas/fisiología , Proteína Quinasa C/fisiología , beta Catenina , Proteínas de Unión al GTP rac/fisiología
4.
FASEB J ; 16(9): 1064-76, 2002 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-12087068

RESUMEN

Bordetella pertussis is an important cause of infection in humans worldwide, with full expression of the syndrome associated with characteristic increases in lung permeability and airway edema. The exact cellular mechanisms by which pertussis toxin (PTX) exerts pulmonary toxicity remain unknown, but may involve its ability to ADP-ribosylate-specific G-proteins. We determined that PTX directly and reproducibly reduced lung endothelial and epithelial cell barrier function in vitro and in vivo assessed by decreases in transmonolayer electrical resistance (TER) and isolated perfused lung preparations. Alterations in lung permeability began approximately 30 min after PTX and were dependent on intrinsic ADP-ribosyltransferase activity, as neither the cell binding beta-oligomer subunit or a genetically engineered PTX mutant (devoid of ADP-ribosyltransferase activity) altered TER. PTX-induced barrier dysfunction was associated with mild increases in F-actin stress fiber formation and causally linked to p38 MAP kinase activities. PTX-mediated p38 MAP kinase activation did not involve either p42/p44 ERK, p60src, Rho family of GTPases, or phosphatidylinositol-3' kinase pathways. PTX-mediated decreases in TER were temporally linked to phosphorylation of the actin binding proteins Hsp27 and caldesmon, known substrates for the Ser/Thr kinase MAPKAP2, whose activity is regulated by p38 MAP kinase. In addition to defining novel signaling pathways involved in PTX-induced respiratory pathophysiology, these data suggest that the direct cell-activating effects of PTX be carefully considered as a potential limitation to its use as a tool in signal transduction analysis.


Asunto(s)
Citoesqueleto de Actina/efectos de los fármacos , Pulmón/efectos de los fármacos , Proteínas Quinasas Activadas por Mitógenos/fisiología , Toxina del Pertussis , Factores de Virulencia de Bordetella/farmacología , Citoesqueleto de Actina/ultraestructura , Animales , Proteínas de Unión a Calmodulina/metabolismo , Bovinos , Células Cultivadas , Impedancia Eléctrica , Endotelio Vascular/efectos de los fármacos , Endotelio Vascular/fisiología , Endotelio Vascular/ultraestructura , Hurones , Proteínas de Choque Térmico/metabolismo , Humanos , Cinética , Pulmón/fisiología , Pulmón/ultraestructura , Fosforilación , Poli(ADP-Ribosa) Polimerasas/metabolismo , Mucosa Respiratoria/efectos de los fármacos , Mucosa Respiratoria/fisiología , Proteínas Quinasas p38 Activadas por Mitógenos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...